European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

ESTIV, ASCCT, JSAAE Joint Webinar in December: Registration Open!

We are pleased to announce this year’s joint webinar with The Japanese Society for Alternatives to Animal Experiments…

ESTIV Awards at the JSAAE 2025 Congress

  • News

as proud to present this year’s ESTIV Awards at the JSAAE Annual Congress 2025, recognizing outstanding contributions from early-career researchers advancing non-animal methods (NAMs) and innovative in vitro toxicology approaches.

Akademie Fresenius International Read-Across Online Conference 2026

  • News

We are pleased to inform you that Akademie Fresenius is organizing another International Read-Across Online Conference…

Silver Sponsor

Memorandum of Understanding